Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?
NCT01865825 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2017-03-22
Summary
The investigators would like to determine if there are patients with PPI responsive Eosinophilic Esophagitis Infiltration that have significant loss of esophageal distensibility suggestive of esophageal fibrosis typical of classic Eosniophilic Esophagitis.
If this group of patients exists, the investigators would like to determine if they have the typical endoscopic features of EoE rather than those of GERD.
Conditions
- Erosive Esophagitis
Interventions
- RADIATION
-
Esophageal Barium Xray
•Fast for 4 hours prior to the Esophagram (upper GI x-ray). You will drink a liquid that has barium or another contrast agent in it. The radiologist will use the X-ray machine to look at your upper GI tract while you drink the contrast liquid. The x-ray exam should take between 10-15 minutes. We will have patients complete the Mayo Dysphasia Questionnaire-30 day.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Jeffrey Alexander, MD · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2016-12-31
- Completion
- 2017-03-31
Countries
- United States
Study Locations
More Related Trials
-
Local Clinical and Immunological Responses in Eosinophilic Esophagitis (EoE) Patients, Role of Mucosal Barrier Function and Type II Inflammation
NCT07012928 ·Status: RECRUITING
-
Influence of Acid Reflux on Stromal Epithelial Interaction in Barrett's Esophagus
NCT01281618 ·Status: COMPLETED
-
Monocentric Retrospective Observational Study for Validation of Meta-analysis of the Metatrascryptome and Transcriptome of Eosynophyl Esophagitis
NCT06071585 ·Status: NOT_YET_RECRUITING
-
The Role of HRM and Specific Biomarkers of Inflammation in the Diagnosis of Patients With Dysphagia and Suspected EoE
NCT04803162 ·Status: UNKNOWN
-
Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus
NCT00573911 ·Status: COMPLETED ·Phase: PHASE1
-
Allergy Immunotherapy in the Management of Eosinophilic Esophagitis
NCT01685034 ·Status: WITHDRAWN ·Phase: NA
-
Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study
NCT03312686 ·Status: RECRUITING
-
Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis
NCT03822325 ·Status: ACTIVE_NOT_RECRUITING
-
Characterization of the Neo-squamous Epithelial Barrier
NCT03077594 ·Status: COMPLETED
-
The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis
NCT02353078 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis
NCT00123656 ·Status: COMPLETED ·Phase: PHASE2
-
Screening for Barrett's Esophagus in Otolaryngology Patients
NCT00695227 ·Status: COMPLETED ·Phase: NA
-
Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis
NCT00895817 ·Status: COMPLETED ·Phase: NA
-
Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index
NCT00939263 ·Status: UNKNOWN
-
A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole
NCT05055128 ·Status: COMPLETED ·Phase: PHASE2
-
Routine Screening for Eosinophilic Esophagitis in Patients Presenting With Dysphagia
NCT01028235 ·Status: UNKNOWN
-
Gastro-oesophageal Reflux in Oligosymptomatic Patients With Dental Erosion
NCT02087345 ·Status: UNKNOWN
-
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
NCT06687603 ·Status: RECRUITING ·Phase: NA
-
Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux
NCT00373997 ·Status: COMPLETED ·Phase: PHASE4
-
Food Antigen in Eosinophilic Esophagitis
NCT02434705 ·Status: COMPLETED
-
Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)
NCT00222170 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis
NCT00880906 ·Status: COMPLETED ·Phase: NA
-
A Prospective, Observational Study of the PPI Non-responder
NCT03282084 ·Status: WITHDRAWN
-
Epithelial Damage in GERD
NCT01867931 ·Status: COMPLETED
-
Biology in Patients With Reflux Esophagitis
NCT01194323 ·Status: COMPLETED